VVOS 8-K 2026-09-30

Vivos Therapeutics, Inc. (VVOS) 8-K dated 2026-09-30 — accession 0001493152-26-045193. This URL is the filing, not the VVOS hub.

Vivos Therapeutics, Inc. (VVOS) is a medical devices company listed on NASDAQ.

Vivos Therapeutics, Inc. filed a 8-K on 2026-09-30. Accession 0001493152-26-045193.

Cached items: 4.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VVOS revenue for 2025-12-31 was $17.4M. Net income was -$21.2M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VVOS currently screens at market cap $7.1M.

Not investment advice. The VVOS SEC hub lists recent forms. The stock page is the research view.